327 related articles for article (PubMed ID: 6302168)
1. [Relapses of malignant nonseminomatous germinal testicular tumors].
Piot G; Droz JP; Caillaud JM; Bellet D; Wibault P; Brulé G; Amiel JL
J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
[TBL] [Abstract][Full Text] [Related]
2. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
3. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
Lowe BA
Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
[TBL] [Abstract][Full Text] [Related]
4. Optimal management of retroperitoneal metastatic nonseminomatous testicular cancer: toward a better selection between scalpel and needle.
de Wit R
J Clin Oncol; 2007 Dec; 25(35):5550-2. PubMed ID: 18065727
[No Abstract] [Full Text] [Related]
5. Results of treatment of non-seminomatous tumours of the testis in pathological stage I.
Wobbes T; Schraffordt Koops H; Oldhoff J; Sleijfer DT; Oosterhuis JW
Neth J Surg; 1983 Jul; 35(3):89-93. PubMed ID: 6310445
[No Abstract] [Full Text] [Related]
6. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
[TBL] [Abstract][Full Text] [Related]
7. Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
von Eschenbach AC; Swanson DA; Johnson DE; Wishnow KI; Stephenson RA; Babaian RJ
Prog Clin Biol Res; 1991; 370():385-92. PubMed ID: 1718009
[No Abstract] [Full Text] [Related]
8. Prognostic factors in nonseminomatous testicular cancer.
Javadpour N
Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
[No Abstract] [Full Text] [Related]
9. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with non-seminomatous germ cell tumours stage I.
Rørth M; Cullen MH; Horwich A; Roth BJ
Prog Clin Biol Res; 1990; 357():295-303. PubMed ID: 2170995
[No Abstract] [Full Text] [Related]
11. The management of stage I nonseminomatous testicular germ cell tumors.
Pectasides D; Farmakis D; Pectasides M
Oncology; 2006; 71(3-4):151-8. PubMed ID: 17646698
[TBL] [Abstract][Full Text] [Related]
12. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
[TBL] [Abstract][Full Text] [Related]
13. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
[TBL] [Abstract][Full Text] [Related]
14. [Role of the excision of thoracic lesions in the treatment of metastatic malignant germinal tumors of the testis].
Richer O; Droz JP; Lemoine G; Levasseur P; Amiel JL; Brulé G
J Urol (Paris); 1982; 88(6):349-51. PubMed ID: 6184419
[TBL] [Abstract][Full Text] [Related]
15. [Delayed retroperitoneal lymph node excision in treatment of advanced non-seminomatous germinal cell tumors. I. Intraoperative findings in marker converted tumor].
Otto T; Goepel M; Seeber S; Rübben H
Urologe A; 1993 May; 32(3):189-93. PubMed ID: 7685554
[TBL] [Abstract][Full Text] [Related]
16. [Follow-up of patients with localized germinal testicular tumors: 6 years' experience at the "Santa Creu i Sant Pau" Hospital].
Climent Duran MA; Germa Lluch JR; Seguí Palmer MA; Fernández Sagarra A; Izquierdo Delso MA; Lacasta Muñoa A
Arch Esp Urol; 1992; 45(1):21-4. PubMed ID: 1316741
[TBL] [Abstract][Full Text] [Related]
17. Wait-and-see policy in clinical stage I non-seminomatous germ cell tumors of the testis.
Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Marrink J; de Bruijn HW; Oldhoff J
Eur J Surg Oncol; 1986 Sep; 12(3):283-7. PubMed ID: 3019779
[TBL] [Abstract][Full Text] [Related]
18. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
19. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
[TBL] [Abstract][Full Text] [Related]
20. Metastatic pathways of nonseminomatous germ cell tumors.
Donohue JP
Semin Urol; 1984 Nov; 2(4):217-29. PubMed ID: 6095396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
